Reduced subendocardial ryanodine receptors and consequent effects on cardiac function in conscious dogs with left ventricular hypertrophy

Circulation Research

Volumn 84, Issue 9, 1999, Pages 999-1006

  Hittinger, Luc ^b   Ghaleh, Bijan ^a   Chen, Jie ^a   Edwards, John G ^a   Kudej, Raymond K ^a   Iwase, Mitsunori ^a   Kim, Song Jung ^a   Vatner, Stephen F ^a   Vatner, Dorothy E ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b INSERM   (France)

Author keywords

Ca2+; Diastole; Pressure overload hypertrophy; Sarcoplasmic reticulum; Systole

Indexed keywords

RYANODINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONSCIOUSNESS; CORONARY ARTERY CIRCUMFLEX BRANCH; DOG; EXCITATION CONTRACTION COUPLING; FLOW RATE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; LIGAND BINDING; NONHUMAN; PRESSURE TRANSDUCER; PRIORITY JOURNAL; SARCOLEMMA; TRANSDUCER;

EID: 0033553542     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.9.999     Document Type: Article

References (45)

1. Kahn M, Shiffman I, Kuhn LA, Jacobson TE. Effects of ryanodine in normal dogs and in those with digitalis-induced arrhythmias: hemodynamic and electrocardiographic studies. Am J Cardiol. 1964;14:658-668.
2. Kalthof B, Sato N, Iwase M, Shen YT, Mirsky I, Patrick TA, Vatner SF. Effects of ryanodine on cardiac contraction, excitation-contraction coupling and "Treppe" in the conscious dog. J Mol Cell Cardiol 1995-27:2111-2121.
3. Lew WY. Mechanisms of volume-induced increase in left ventricular contractility. Am J Physiol. 1993;265:H1778-H1786.
4. Procita L. Some pharmacological actions of ryanodine in the mammal. J Pharmacol Exp Ther. 1958;123:296-305.
5. Takasago T, Goto Y, Kawaguchi O, Hata K, Saeki A, Nishioka T, Suga H. Ryanodine wastes oxygen consumption for Ca2+ handling in the dog heart. A new pathological heart model. J Clin Invest. 1993;92:823-830.
6. Prabhu SD, Rozek MM, Murray DR, Freeman GL. Ryanodine and left ventricular function in intact dogs: dissociation of force-based and velocity-based indexes. Am J Physiol. 1997;273:H1561-H1568.
7. Ohkusa T, Hisamatsu Y, Yano M, Kobayashi S, Tatsuno H, Saiki Y, Kohno M, Matsuzaki M. Altered cardiac mechanism and sarcoplasmic reticulum function in pressure overload-induced cardiac hypertrophy in rats. J Mol Cell Cardiol. 1997;29:45-54.
8. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science. 1997;276:800-806.
9. 2+ release channel function in sarcoplasmic reticulum of pressure-overload-induced hypertrophic rat heart. J Mol Cell Cardiol. 1994;26:1505-1512.
10. Naudin V, Oliviero P, Rannou F, Sainte Beuve C, Charlemagne D. The density of ryanodine receptors decreases with pressure overload-induced rat cardiac hypertrophy. FEBS Lett. 1991;285:135-138.
11. Rannou F, Sainte-Beuve C, Oliviero P, Do E, Trouve P, Charlemagne D. The effects of compensated cardiac hypertrophy on dihydropyridine and ryanodine receptors in rat, ferret and guinea-pig hearts. J Mol Cell Cardiol. 1995;27:1225-1234.
12. Arai M, Suzuki T, Nagai R. Sarcoplasmic reticulum genes are upregulated in mild cardiac hypertrophy but downregulated in severe cardiac hypertrophy induced by pressure overload. J Mol Cell Cardiol 1996;28:1583-1590.
13. Matsui H, MacLennan DH, Alpert NR, Periasamy M. Sarcoplasmic reticulum gene expression in pressure overload-induced cardiac hypertrophy in rabbit. Am J Physiol. 1995;268:C252-C258.
14. Limas CJ, Spier SS, Kahlon J. Enhanced calcium transport by sarcoplasmic reticulum in mild cardiac hypertrophy. J Mol Cell Cardiol 1980;12:1103-1116.
15. Holmberg SRM, Williams AJ. Single channel recordings from human cardiac sarcoplasmic reticulum. Circ Res. 1989;65:1445-1449.
16. Sainte Beuve C, Allen PD, Dambrin G, Rannou F, Marty I, Trouve P, Bors V, Pavie A, Gandgjbakch I, Charlemagne D. Cardiac calcium release channel (ryanodine receptor) in control and cardiomyopathic human hearts: mRNA and protein contents are differentially regulated. J Mol Cell Cardiol. 1997;29:1237-1246.
17. Schumacher C, Konigs B, Sigmund M, Kohne B, Schondube F, Vob M, Stein B, Weil J, Hanrath P. The ryanodine binding sarcoplasmic reticulum calcium release channel in nonfailing and in failing human myocardium. Naunyn Schmiedebergs Arch Pharmacol. 1995;353:80-85.
18. 2+ accumulation in nonfailing and failing human myocardium. Circulation. 1995;92:2504-2510.
19. Cory CR, McCutcheon LJ, O'Grady M, Pang AW, Geiger JD, O'Brien PJ. Compensatory downregulation of myocardial Ca channel in SR from dogs with heart failure. Am J Physiol. 1993;264:H926-H937.
20. Vatner DE, Sato N, Kiuchi K, Shannon RP, Vatner SF. Decrease in myocardial ryanodine receptors and altered excitation-contraction coupling early in the development of heart failure. Circulation. 1994-90: 1423-1430.
21. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 1995;92:778-784.
22. Schillinger W, Meyer M, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Unaltered ryanodine receptor protein levels in ischemic cardiomyopathy. Mol Cell Biochem. 1996;160-161:297-302.
23. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 1993;72:463-469.
24. Brillantes AM, Allen P, Takahashi T, Izumo S, Marks AR. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res. 1992;71:18-26.
25. Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest. 1995;95:888-894.
26. Bache RJ, Vrobel TR, Arentzen CE, Ring WS. Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in dogs with left ventricular hypertrophy. Circ Res. 1981;49:742-750.
27. Hittinger L, Shannon RP, Bishop SP, Gelpi RJ, Vatner SF. Subendomyocardial exhaustion of blood flow reserve and increased fibrosis in conscious dogs with heart failure. Circ Res. 1989;65:971-980.
28. Hittinger L, Shannon RP, Kohin S, Manders WT, Kelly P, Vatner SF. Exercise-induced subendocardial dysfunction in dogs with left ventricular hypertrophy. Circ Res. 1990;66:329-343.
29. Lew WY. Asynchrony and ryanodine modulate load-dependent relaxation in the canine left ventricle. Am J Physiol. 1995;268:H17-H24.
30. Ohnishi ST, Katsuoka M. Why does halothane relax cardiac muscle but contract malignant hyperthermic skeletal muscle? Adv Exp Med Biol. 1991;301:73-87.
31. Pagel PS, Kampine JP, Schmeling WT, Warltier DC. Alteration of left ventricular diastolic function by desflurane, isoflurane, and halothane in the chronically instrumented dog with autonomie nervous system blockade. Anesthesiology. 1991;74:1103-1114.
32. Gwirtz PA. Construction and evaluation of a coronary catheter for chronic implantation in dogs. J Appl Physiol. 1986;60:720-726.
33. Lowry OH, Rosebrough NF, Farr AL, Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem. 1951;193:265-275.
34. Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980;107:220-239.
35. Edwards JG, Lyons GE, Micales BK, Malhotra A, Factor S, Leinwand LA. Cardiomyopathy in transgenic myf5 mice. Circ Res. 1996;78: 379-387.
36. Bache RJ, Vrobel TR, Ring WS, Emery RW, Andersen RW. Regional myocardial blood flow during exercise in dogs with chronic left ventricular hypertrophy. Circ Res. 1981;48:76-87.
37. 2+ channels. Circ Res. 1994;74:271-280.
38. 2+ channels. A possible mechanism of ischemic preconditioning. Circ Res. 1995;76: 1049-1056.
39. Matsuda H, McCully JD, Levitsky S. Developmental differences in cytosolic calcium accumulation associated with global ischemia: evidence for differential intracellular calcium channel receptor activity. Circulation. 1997;96:II-233-II-239.
40. Thandroyen FT, McCarthy J, Burton KP, Opie LH. Ryanodine and caffeine prevent ventricular arrhythmias during acute myocardial ischemia and reperfusion in rat heart. Circ Res. 1988;62:306-314.
41. Karliner JS, LeWinter MM, Mahler F, Engler R, O'Rourke RA. Pharmacologic and hemodynamic influences on the rate of isovolumic left ventricular relaxation in the normal conscious dog. J Clin Invest. 1977; 60:511-521.
42. Mill JG, Novaes MAS, Galon M, Nogueira JB, Vassallo DV. Comparison of the contractile performance of the hypertrophied myocardium from spontaneous hypertensive rats and normotensive infarcted rats. Can J Physiol Pharmacol. 1998;76:387-394.
43. Bers DM. Control of cardiac contraction by SR Ca release and sarcolemmal Ca fluxes. In: Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht, the Netherlands: Kluwer Academic Publishers; 1991:150.
44. Bers DM, Stiffel VM. Ratio of ryanodine to dihydropyridine receptors in cardiac and skeletal muscle and implications for E-C coupling. Am J Physiol. 1993;264:C1587-C1593.
45. Hugtenburg JG, Mathy MJ, Boddeke HW, Beckeringh JJ, van Zwieten PA. Differences between negative inotropic and vasodilator effects of calcium antagonists acting on extra- and intracellular calcium movements in rat and guinea-pig cardiac preparations. Naunyn Schmiedebergs Arch Pharmacol. 1989;340:567-575.